Stricture and perforation of the esophagus: Overlooked threats in the Zollinger-Ellison syndrome [PDF]
, 1990 This study was undertaken to assess the frequency of significant esophageal involvement in the Zollinger-Ellison syndrome (ZES). In a consecutive series of 24 patients with this disease, 9 (37%) showed endoscopic evidence of acid-induced esophageal ...
Thompson, Norman W. +2 more
core +1 more source
Duodenal gastrinomas, duodenotomy, and duodenal exploration in the surgical management of Zollinger-Ellison syndrome [PDF]
, 1993 Studies have shown that the duodenum is a more common site (30–40%) of primary gastrinomas than previously reported. These tumors are often occult to conventional exploration, and their detection requires duodenotomy and meticulous evaluation of the ...
Fukuuchi, Atsushi +2 more
core +1 more source
Zollinger-Ellison syndrome, acromegaly, and colorectal neoplasia [PDF]
, 1997 Zollinger-Ellison syndrome (ZES) and acromegaly are two hypersecretory states in which colorectal neoplasia has been described, but the incidence in the former condition may not be increased. We describe four patients with colorectal neoplasia associated
Maliakkal, BJ +6 more
core +2 more sources
Current Concepts on Gastric Carcinoid Tumors
Gastroenterology Research and Practice, 2012 Gastric carcinoid tumors (GCs) are rare lesions representing less than 10% of carcinoid tumors and less than 1% of all stomach neoplasms. There are three distinct types of gastric carcinoids; type I includes the vast majority (70–85%) of these neoplasms ...
George C. Nikou +1 more
doaj +1 more source
Zollinger-Ellison Syndrome: A Narrative Review of Clinical Presentation, Pathogenesis, Diagnosis and Modern Management Approaches [PDF]
Journal of Clinical and Diagnostic ResearchZollinger-Ellison Syndrome (ZES) is rare disorder which is caused by gastrin-secreting neuroendocrine tumours known as gastrinomas, primarily located in the duodenum or pancreas.
Jaideep Reddy +4 more
doaj +1 more source
Review: A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers
Therapeutic Advances in Gastroenterology, 2010 Intravenous (IV) proton-pump inhibitors (PPIs) are potent gastric acid suppressing agents, and their use is popular in clinical practice. Both IV and oral PPIs have similarly short half-lives, and their effects on acid secretion are similar, thus their ...
Sandy H. Pang, David Y. Graham
doaj +1 more source
Balancing therapeutic benefits and hidden risks of proton pump inhibitors in pediatric practice: a narrative review and update [PDF]
Clinical and Experimental PediatricsProton pump inhibitors (PPIs) are drugs whose main effect is catalytic and long-lasting suppression of gastric acid secretion, with an anti-inflammatory effect.
Maria Rogalidou, Alexandra Papadopoulou
doaj +1 more source
Zollinger-Ellison Syndrome: Methods of Diagnosis and Treatment [PDF]
, 1990 Until two decades ago the Zollinger-Ellison syndrome (ZES) was difficult to diagnose and stage accurately. Total gastrectomy was often the ultimate treatment.
Sangal, Ajay K. +3 more
core +1 more source
Revista do Colégio Brasileiro de CirurgiõesGastrinomas are generally localized in pancreas, duodenum and lymphonodes, within the so called "gastrinoma's triangle" . In 5% of the cases, it may arise from liver, stomach, ovarium, kidneys, parathyroid, omentum, jejunum and heart.
Antônio Carlos Valezi +1 more
doaj +1 more source
Primary gastrinoma of the gallbladder: a case report and review of the literature
Frontiers in OncologyBackgroundPrimary gallbladder gastrinoma is an exceptionally uncommon tumor and is a rare form of neuroendocrine neoplasm. Until now, no cases of primary gallbladder gastrinoma and rare cases of primary gastrinoma from the biliary system have been ...
Yao-Ge Liu +7 more
doaj +1 more source